Vimarsana
Biggest News Aggregation in the World

Page 4 - Accelerate Commercialization News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Accelerate Commercialization. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Accelerate Commercialization Today - Breaking & Trending Today

Merck snares $269M in U.S. funding to prep manufacturing for Johnson & Johnson's COVID-19 vaccine - Vimarsana News

Merck snares $269M in U.S. funding to prep manufacturing for Johnson & Johnson's COVID-19 vaccine

Merck's "wartime" coronavirus tie-up with Johnson & Johnson puts the vaccine giant on deck to support drug substance, formulation and vial-filling work in the U.S. And the government is chipping in with $269 million to equip two Merck manufacturing plants for the work.

FDA slaps FibroGen, AstraZeneca with last-minute roxadustat AdCom, cuing another delay for anemia drug - Vimarsana News

FDA slaps FibroGen, AstraZeneca with last-minute roxadustat AdCom, cuing another delay for anemia drug

Mar 3, 2021 10:50am The FDA has sent a last-minute notification of an advisory committee review of FibroGen and AstraZeneca's first-in-class anemia candidate roxadustat, threatening another decision delay. (FDA) FibroGen and AstraZeneca already endured a delay in the U.S. review of their anemia candidate roxadustat. Just as the pair was expecting to snag its first-in-class approval, as the revised date draws near, a capricious FDA has stunned the companies with a second blow. The FDA will convene an advisory committee to review roxadustat’s application for treating anemia caused by chroni...

Gilead cuts jobs in California, moving some to new North Carolina business center - Vimarsana News

Gilead cuts jobs in California, moving some to new North Carolina business center

Gilead Sciences plans to cut more than 170 jobs in California, as it builds a new business services center in North Carolina. The Foster City-based pharma will transfer about half of the jobs to the consolidated services hub now under construction in the Research Triangle Park area.

What does it take to supply COVID-19 vaccines across the globe? Here's how the leading players are working it - Vimarsana News

What does it take to supply COVID-19 vaccines across the globe? Here's how the leading players are working it

Mar 3, 2021 9:45am COVID-19 vaccine shipments are now underway. Here are the supply chains tasked with producing billions of doses. (nevodka/iStock/Getty Images Plus/Getty Images) As COVID-19 gained steam worldwide last spring, little was known about the disease and the havoc it would wreak on the world. A year later, vaccines offer hope in the fight against the virus, but it will be a monumental task to produce them and deliver them around the planet. That these vaccines were invented, put through clinical testing and either have been rolled out or are nearing distribution is an accomplishm...

CDMO Celonic to beef up cell and gene therapy work at up-and-coming Novartis hub - Vimarsana News

CDMO Celonic to beef up cell and gene therapy work at up-and-coming Novartis hub

Mar 3, 2021 12:19pm Novartis in February said it would convert manufacturing operations in Stein, Switzerland, into a life sciences hub focused on cell and gene therapy production. (Novartis) Like many CDMOs these days, Switzerland's Celonic aims to make a big splash in cell and gene therapy—and it's picked up space at an emerging Novartis life sciences hub to take that work to the next level.  Celonic sewed up a long-term lease for production and office space in the WST-222 building of Novartis’ hub-to-be in Stein, Switzerland, dubbed Life Science Park Rheintal. The company will use ...